Evidence map›Paper›PMID 42279031›Full record

ArticleJournal of clinical medicine2026

Re-Analyzing Differentiated High-Grade Thyroid Carcinoma and Elevated Ki-67 Proliferation: A Single-Center Retrospective Study.

Gülsüm Karaahmetli, Şefika Burçak Polat, Sevgül Fakı, Leyla Akdoğan, Feride Pınar Altay, Birgül Genç, Ayşegül Aksoy Altınboğa, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakır

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gülsüm KaraahmetliDepartment of Endocrinology and Metabolism, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.ORCID 0000-0002-5883-3545
Şefika Burçak PolatDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye.
Sevgül FakıDepartment of Endocrinology and Metabolism, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.ORCID 0000-0003-1856-1263
Leyla AkdoğanDepartment of Endocrinology and Metabolism, Kirikkale High Specialization Hospital, Kirikkale 71450, Türkiye.
Feride Pınar AltayDepartment of Endocrinology and Metabolism, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.ORCID 0000-0002-6790-3031
Birgül GençDepartment of Endocrinology and Metabolism, Health Sciences Institute, Ankara Yıldırım Beyazıt University, Ankara 06800, Türkiye.
Ayşegül Aksoy AltınboğaDepartment of Pathology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye.
Oya TopaloğluDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye.
Reyhan ErsoyDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye.ORCID 0000-0002-7437-1176
Bekir ÇakırDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

differentiated high-grade thyroid carcinomaKi-67 proliferation indexmitosisnecrosispapillary thyroid carcinomaprognosis

Identifiers

PMID42279031
PMCPMC13258479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.